Market Overview

Milberg LLP Announces Pendency of Class Action Lawsuits Filed Against Peregrine Pharmaceuticals

Related PPHM
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Avid Bioservices Announces Expansion Of cGMP Manufacturing Capacity
Phase II Clinical Data of Peregrine Pharmaceuticals' Bavituximab in Combination With Sorafenib ... (GuruFocus)

Milberg LLP announces that class action lawsuits were filed in the United States District Court for the Central District of California on behalf of purchasers of Peregrine Pharmaceuticals, Inc. (“Peregrine”) (NASDAQ: PPHM) common stock during the period July 16, 2012 to September 26, 2012, (the “Class Period”).

Milberg LLP has created a website ( that seeks to answer common questions about shareholder class actions.

Posted-In: News FDA


Related Articles (PPHM)

Around the Web, We're Loving...

Get Benzinga's Newsletters